Wed, Jan 20, 2021
NYSE: ABBV $195 Billion Large-Cap. New 52 WEEK HIGH Wednesday. S&P 500. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 93%. 1 Year Return 28%. 2021 YTD Return 7%. 4.6% dividend yield. 33 total dividend payments. Dividend Aristocrats. 25+ consecutive years of increasing dividends. Earnings in 14 days on Wed, Feb 3.
The 52 Week Low is $62.55 set on Mon, Mar 23, 2020.
The 52 Week High is $113.10 set on Wed, Jan 20, 2021.
The All-Time High is $125.86 set on Fri, Jan 26, 2018.
Earnings Per Share
Price To Earnings Ratio
Dividend Payment Date
AbbVie trades on the NYSE. ABBV's market cap is 195.1 Billion.
AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.